Paul J. Utz, MD, PhD | Scientific Advisory Board
12521
page-template,page-template-templates,page-template-page-fullwidth,page-template-templatespage-fullwidth-php,page,page-id-12521,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,columns-4,qode-theme-ver-11.1,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

Paul J. Utz, MD, PhD

Professor of Medicine, Immunology and Rheumatology
Stanford University, Stanford, CA

Dr. Paul J. Utz is an expert in the study of human and murine autoantibodies and autoantigens, apoptosis signaling pathways, animal models of autoimmunity, proteomics and multiplexed assay development for biomarker discovery.

While earning his M.D. degree in 1991 from Stanford, Dr. Utz co-discovered the transcription factor Nuclear Factor of Activated T Cells (NFAT) with J.P. Shaw in Dr. Gerald Crabtree’s laboratory. He completed his internal medicine residency, rheumatology fellowship, and post-doctoral training at Brigham and Women’s Hospital in Boston prior to joining the Harvard Medical School Faculty in 1996. He joined the Stanford University faculty in 1999 and was promoted to Associate Professor of Medicine in 2005 and Professor in 2012.

Dr. Utz directs a lab in the Division of Immunology at Stanford University School of Medicine. He actively collaborates with many investigators on the Stanford campus, and across the world, with a goal to disseminate and implement newly invented technologies. The Utz lab studies autoimmune diseases, pathogenic mechanisms involved in autoimmunity, and develops bench-to-bedside technologies for human immune diseases.

He is Director of Stanford’s Autoimmunity Center of Excellence and serves as the principal investigator of the Accelerating Medicines Partnership in RA/SLE initiative, a collaborative program to accelerate treatments from laboratory to patients between academia, the pharmaceutical industry and the National Institutes of Health.